In contrast, patients in the T3 group were more often older and had higher heart rate and hs-CRP levels, STEMI, diabetes, prior HF, previous MI, history of stroke, elevated NT-proBNP, IABP, multivessel or triple-vessel disease, primary PCI, and β-blocker treatment. The gene discussed is NPPB; the disease is stroke disorder.